Experimental Study: Effect of Promotional Offers in Direct-to-Consumer Prescription Drug Print Advertisements on Consumer Product Perceptions

ICR 201301-0910-005

OMB: 0910-0713

Federal Form Document

Forms and Documents
Document
Name
Status
Supplementary Document
2013-01-17
Justification for No Material/Nonsubstantive Change
2013-01-17
IC Document Collections
IC ID
Document
Title
Status
199763 Modified
199762 Modified
199761 Modified
199760 Modified
199759 Modified
ICR Details
0910-0713 201301-0910-005
Historical Active 201110-0910-006
HHS/FDA
Experimental Study: Effect of Promotional Offers in Direct-to-Consumer Prescription Drug Print Advertisements on Consumer Product Perceptions
No material or nonsubstantive change to a currently approved collection   No
Regular
Approved without change 01/29/2013
Retrieve Notice of Action (NOA) 01/18/2013
  Inventory as of this Action Requested Previously Approved
06/30/2015 06/30/2015 06/30/2015
15,344 0 15,344
2,561 0 2,561
0 0 0

This study will examine what effect, if any, the presence of price incentive promotional offers in DTC prescription drug ads have on the following: (1) Consumers' perceptions of product risks and benefits, (2) recall of product risks and benefits, and (3) strongly held beliefs that may act as potential moderators.

None
None

Not associated with rulemaking

Yes

5
IC Title Form No. Form Name
Screener
Pretests
Study 1 - Online
Study 1 - Mall Intercept
Study 2

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 15,344 15,344 0 0 0 0
Annual Time Burden (Hours) 2,561 2,561 0 0 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No

$924,365
Yes Part B of Supporting Statement
No
No
No
No
Uncollected
Daniel Gitteson 3017965156 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
01/18/2013


© 2022 OMB.report | Privacy Policy